Study Results & Research Projects

Summaries & Associations of Study Results

TR-440 Ozone (2-year study)

Print this page Easy Link

http://ntp.niehs.nih.gov/go/8658

Target Organs and Levels of Evidence
NTP Technical Report Number 440

Produced from Chemtrack Database 09/19/01

CHEMICAL/ CAS NUMBER PEER REVIEW DATE PRIMARY USES ROUTE/EXPOSURE LEVELS STUDY LABORATORY
OZONE
10028-15-6
11/16/93 POLLUTION CONTROL, WASTE TREATMENT, CHEMICAL SYNTHESIS, STERILIZATION WHERE RESIDUALS OF OTHER CHEMICALS WOULD BE OBJECTIONABLE, ODOR CONTROL, BLEACHING WAXES, CLAY, TEXTILES, PAPER PULP, OILS, CONTROL OF ALGAE, MOLD, AND BACTERIA Inhalation R&M: 0, 0.12, 0.5, OR 1.0 PPM (50/SEX/SPECIES/GROUP) Battelle Northwest Laboratory
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM):
MR: NO EVIDENCE
NON-NEOPLASTIC LESIONS: NOSE: (2 YR. STUDY) GOBLET CELL AND LATERAL WALL HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (2 YR. STUDY) SQUAMOUS METAPLASIA
LUNG: (2 YR. STUDY) METAPLASIA; INTERSTITIAL FIBROSIS
FR: NO EVIDENCE
NON-NEOPLASTIC LESIONS: NOSE: (2 YR. STUDY) GOBLET CELL AND LATERAL WALL HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (2 YR. STUDY) SQUAMOUS METAPLASIA
LUNG: (2 YR. STUDY) METAPLASIA; INTERSTITIAL FIBROSIS
MM: EQUIVOCAL EVIDENCE LUNG: (2 YR. STUDY) ALVEOLAR/BRONCHIOLAR ADENOMA 6/50 9/50 12/50 11/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 8/50 4/50 8/50 10/50 COMBINED 14/50 13/50 18/50 19/50
NON-NEOPLASTIC LESIONS: NOSE: (2 YR. STUDY) HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (2 YR. STUDY) HYPERPLASIA
LUNG: (2 YR. STUDY) HISTIOCYTIC INFILTRATION; METAPLASIA
FM: SOME EVIDENCE LUNG: (2 YR. STUDY) ALVEOLAR/BRONCHIOLAR ADENOMA 4/50 5/50 5/49 8/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 2/50 2/50 5/49 8/50 COMBINED 6/50 7/50 9/49 16/50
NON-NEOPLASTIC LESIONS: NOSE: (2 YR. STUDY) HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (2 YR. STUDY) HYPERPLASIA
LUNG: (2 YR. STUDY) HISTIOCYCTIC INFILTRATION; METAPLASIA
OZONE
10028-15-6
11/16/93 POLLUTION CONTROL, WASTE TREATMENT, CHEMICAL SYNTHESIS, STERILIZATION WHERE RESIDUALS OF OTHER CHEMICALS WOULD BE OBJECTIONABLE, ODOR CONTROL, BLEACHING WAXES, CLAY, TEXTILES, PAPER PULP, OILS, CONTROL OF ALGAE, MOLD, AND BACTERIA Inhalation R&M: 0, 0.5, OR 1.0 PPM (50/SEX/SPECIES/GROUP) Battelle Northwest Laboratory
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM):
MR: NO EVIDENCE
NON-NEOPLASTIC LESIONS: NOSE: (LIFETIME STUDY) GOBLET CELL AND LATERAL WALL HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (LIFETIME STUDY) SQUAMOUS METAPLASIA
LUNG: (LIFETIME STUDY) METAPLASIA; HISTIOCYTIC INFILTRATION; INTERSTITIAL FIBROSIS
FR: NO EVIDENCE
NON-NEOPLASTIC LESIONS: NOSE: (LIFETIME STUDY) GOBLET CELL AND LATERAL WALL HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (LIFETIME STUDY) SQUAMOUS METAPLASIA
LUNG: (LIFETIME STUDY) METAPLASIA; HISTIOCYTIC INFILTRATION; INTERSTITIAL FIBROSIS
MM: EQUIVOCAL EVIDENCE LUNG: (LIFETIME STUDY) ALVEOLAR/BRONCHIOLAR ADENOMA 8/49 8/49 9/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 8/49 15/49 18/50 COMBINED 16/49 22/49 21/50
NON-NEOPLASTIC LESIONS: NOSE: (LIFETIME STUDY) HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (LIFETIME STUDY) HYPERPLASIA; SQUAMOUS CELL METAPLASIA
LUNG: (LIFETIME STUDY) HISTIOCYTIC INFILTRATION; METAPLASIA
FM: SOME EVIDENCE LUNG: (LIFETIME STUDY) ALVEOLAR/BRONCHIOLAR ADENOMA 3/50 3/49 11/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 3/50 5/49 2/50 COMBINED 6/50 8/49 12/50
NON-NEOPLASTIC LESIONS: NOSE: (LIFETIME STUDY) HYPERPLASIA; SQUAMOUS METAPLASIA
LARYNX: (LIFETIME STUDY) HYPERPLASIA; SQUAMOUS CELL METAPLASIA
LUNG: (LIFETIME STUDY) HISTIOCYTIC INFILTRATION; METAPLASIA
OZONE/NNK
OZONNNKCOMB
11/16/93 BYPRODUCT OF TOBACCO SMOKE Inhalation MALE RATS ONLY: 0, 0.5 PPM OZONE WITH 0, 0.1, 1.0 MG/KG NNK BY S.C. INJECTION (20 WEEKS ONLY) Battelle Northwest Laboratory
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM):
NOTE: IN A COCARCINOGENICITY STUDY, OZONE DID NOT ENHANCE NNK-INDUCED PULMONARY NEOPLASMS IN MALE RATS